Dallah Healthcare completes Care Shield acquisition
Argaam
24/12/2025
| Last Trade | 124.90 |
| Change | 0.90 |
| Change (%) | 0.73 |
| Open | 123.90 |
| Low | 123.90 |
| High | 126.40 |
| Prev. Close | 124.00 |
| Change (3M) | (18.10 %) |
| Change (6M) | (6.37 %) |
| Volume | 76,672 |
| Turnover | 9,571,920.00 |
| Transactions | 739 |
| Market Value | 12,686.72 |
| Avg. Volume (3M) | 63,615.33 |
| Avg. Turnover (3M) | 8,409,619.67 |
| Avg. Transaction (3M) | 1,312.56 |
| Change (12M) | (20.75 %) |
| YTD | (0.48 %) |
|
Event Date
|
Event
|
||
|---|---|---|---|
|
30-11-2025
|
Cash Dividend Distribution | ||
|
10-11-2025
|
Ex-dividend Date | ||
|
19-10-2025
|
General Assembly | ||
|
04-09-2025
|
Cash Dividend Distribution | ||
|
17-08-2025
|
Ex-dividend Date | ||
| More | |||
| Report | Interim | Year |
| Dallah earns SAR 421.7M in 9M 2025, SAR 141.9M in Q3 | 9 M | 2025 |
| Dallah H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M | 6 M | 2025 |
| Dallah profit jumps 30% to SAR 155.6M in Q1 2025 | 3 M | 2025 |
| Dallah’s profit rises 31% to SAR 471.2M in 2024; Q4 at SAR 113.9M | 12 M | 2024 |
| Date | Research firm | Rating |
|
|
AlphaMena | Underweight |
|
|
U-Capital | Hold |
|
|
AlJazira Capital | Neutral |
|
|
EFG-Hermes | Buy |
